Zhejiang Orient Gene Biotech to Set Up Philippine Subsidiary for $1.2 Million
Zhejiang Orient Gene Biotech (SHA:688298), through subsidiary Healgen International, will invest $1.2 million for the establishment of a subsidiary in the Philippines, according to a Thursday disclosure on the Shanghai Stock Exchange.
The subsidiary named Healgen Scientific will have a registered capital of 20 million Philippine pesos and will wholesale medical equipment, the Chinese biotechnology company said.
Shares of the company rose more than 1% in recent trade.
Price (RMB): ¥29.52, Change: ¥+0.35, Percent Change: +1.20%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.